OTC · CTTH

CTT Pharmaceutical Holdings, Inc.

Closing price No closing price on file for CTTH from our free price source.
Last insider buy price $0.05 Paid by CEO, Director CTT Pharmaceutical Holdings, Inc. on Nov 4, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2015

Cash got weaker

descriptionFiled Nov 23, 2015
Cash from operationsBetter
−$15.5K
Quarter ended Dec 31, 2013: −$209 cash from operationsQuarter ended Mar 31, 2014: −$330 cash from operationsQuarter ended Jun 30, 2014: −$876 cash from operationsQuarter ended Sep 30, 2014: −$24.2K cash from operationsQuarter ended Dec 31, 2014: −$46.8K cash from operationsQuarter ended Mar 31, 2015: −$39.7K cash from operationsQuarter ended Jun 30, 2015: −$29.2K cash from operationsQuarter ended Sep 30, 2015: −$15.5K cash from operations
Dec '13Sep '15
vs. −$24.2K a year ago
Share countBuying back
−88.4%
Quarter ended Dec 31, 2013: 9.41M sharesQuarter ended Mar 31, 2014: 9.4M sharesQuarter ended Jun 30, 2014: 35.18M sharesQuarter ended Sep 30, 2014: 184.37M sharesQuarter ended Dec 31, 2014: 195.07M sharesQuarter ended Mar 31, 2015: 195.07M sharesQuarter ended Jun 30, 2015: 195.07M sharesQuarter ended Sep 30, 2015: 21.35M shares
Dec '13Sep '15
21.35M shares vs. 184.37M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Buying Insiders: as of Nov 13
−1000+100 +100
  • group
    1 insider bought in the last 30 days. $899 in open-market buys, Oct 15–Nov 4.
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovOpen-market buy · Dec 17 · $498Open-market buy · Aug 7 · $539Open-market buy · Aug 14 · $108Open-market buy · Aug 19 · $600Open-market buy · Aug 20 · $575Open-market buy · Aug 24 · $126Open-market buy · Aug 31 · $175Open-market buy · Sep 2 · $150Open-market buy · Sep 4 · $490Open-market buy · Sep 10 · $175Open-market buy · Sep 16 · $545Open-market buy · Sep 22 · $505Open-market buy · Sep 28 · $204Open-market buy · Oct 6 · $204Open-market buy · Oct 15 · $114Open-market buy · Oct 26 · $335Open-market buy · Nov 4 · $450
CEOCFOOther officersDirectorsJunJulAugSepOctNovOpen-market buy · Aug 7 · $539Open-market buy · Aug 14 · $108Open-market buy · Aug 19 · $600Open-market buy · Aug 20 · $575Open-market buy · Aug 24 · $126Open-market buy · Aug 31 · $175Open-market buy · Sep 2 · $150Open-market buy · Sep 4 · $490Open-market buy · Sep 10 · $175Open-market buy · Sep 16 · $545Open-market buy · Sep 22 · $505Open-market buy · Sep 28 · $204Open-market buy · Oct 6 · $204Open-market buy · Oct 15 · $114Open-market buy · Oct 26 · $335Open-market buy · Nov 4 · $450

Last 6 months. A wider screen shows 12.

Showing 17 real trades. Bigger dot means a bigger trade.

Real trades, newest first

Nov 4 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $450 9,000 sh at $0.05
Oct 26 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $335 5,880 sh at $0.06
Oct 15 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $114 2,000 sh at $0.06
Oct 6 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $204 3,700 sh at $0.06
Sep 28 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $204 3,400 sh at $0.06
Sep 22 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $505 10,100 sh at $0.05
Sep 16 CTT Pharmaceutical Holdings, Inc. CEO, Director Open-market buy $545 10,900 sh at $0.05
Sep 10 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $175 3,500 sh at $0.05
Sep 4 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $490 9,800 sh at $0.05
Sep 2 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $150 3,000 sh at $0.05
Show 7 older real trades
Aug 31 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $175 3,500 sh at $0.05
Aug 24 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $126 2,100 sh at $0.06
Aug 20 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $575 11,500 sh at $0.05
Aug 19 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $600 10,000 sh at $0.06
Aug 14 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $108 1,800 sh at $0.06
Aug 7 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $539 7,700 sh at $0.07
Dec 17 CTT Pharmaceutical Holdings, Inc. CEO Open-market buy $498 8,300 sh at $0.06

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in CTTH

No 13F holdings loaded for this stock.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast